Use of aptamers as a therapeutic targeting moiety, holds the promise of building on the success of ADCs. Aptamers have several advantages over mAbs as a targeting moiety including: (i) smaller size that enables better tissue/tumor penetration; (ii) chemical synthesis which allows rapid and afford...
Henlius’ phase 3 clinical study of its innovative anti-PD-1 monoclonal antibody(mAb) HANSIZHUANG (serplulimab) as first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) was published as poster presentation...
MAIA Biotechnology, Inc. (NYSE American: MAIA ) today announced that it will present a poster that will feature the design of its ongoing Phase 2 clinical trial, THIO-101 evaluating THIO in patients with advanced Non-Small Cell Lung Cancer (NSCLC).
The translational research poster (#2259) is entitled “Novel Metallotherapeutic BOLD-100 Induces Circulating Cytokine Changes When Administered in Combination with FOLFOX in Advanced Gastrointestinal Cancer Patients,” and will be presentedApril 17, 2023at9:00AM. “We are t...
Presenter:Z. LuoDownload poster Genomic Profiling of Tumors 1170Development and analytical validation of a novel next-generation DNA sequencing assay, the Oncomine Lymphoma Panel, to detect SNV, insertion, deletion and copy number variants in 25 Lymphoma genes in FFPE samples ...
Candidates must either be AACAP members or have a membership application pending (not paid by the award) and agree to submit a poster presentation on his or her research for AACAP's 68th Annual Meeting in Atlanta, Geor- gia, October 25-30, 2021. Type: Award Subjects: Child and adolescent...
This DNA endonuclease cuts both strands of a DNA heteroduplex on the 3'-side of the mismatch site, yielding smaller sized fragments that can be detected by size discrimination technologies. Small insertions/deletions as well as all base-substitution mismatches are recognized. SURVEYOR Scan K-RAS ...
2024年4月10日,复宏汉霖(2696.HK)宣布,公司首个创新型单抗H药 汉斯状(斯鲁利单抗)一线治疗广泛期小细胞肺癌(ES-SCLC)的国际多中心III期临床试验ASTRUM-005的探索性生物标志物分析数据在2024年美国癌症协会年会(AACR 2024)上以壁报形式展示,该研究的主要研究者为吉林省肿瘤医院程颖教授。
Candidates must either be AACAP members or have a membership application pending (not paid by the award) and agree to submit a poster presentation on his or her research for AACAP's 68th Annual Meeting in Atlanta, Geor- gia, October 25-30, 2021. Type: Award Subjects: Child and adolescent...
Details on study design, location, data source, patient number, cancer site, analytical approach, endpoints, and presentation type (oral vs. poster) were extracted and analyzed. Searches in Google Scholar identified published manuscripts associated with each abstract. The Cochran-Armitage trend test ...